Coronavirus Update: Lilly Begins Clinical Trial Of Antibody Therapy
Plus News From Resverlogix, Sun And Syntekabio
Discovered at record-breaking speed by AbCellera, Lilly says the antibody candidate could progress into Phase II trials by June.
You may also be interested in...
Independent drug cost watchdog updates its twin pricing estimates for Gilead's drug - but dexamethasone could tip the balance again.
David Ricks says a consortium of companies will be needed to ensure enough doses of the successful candidates are available.
CureVac starts mRNA vaccine trial, Interprotein uses AI in drug discovery and South Korea's Chong Kun and Hanmi make clinical progress.